If you are an Aetna member and received a letter regarding contract negotiations with NewYork-Presbyterian, you may find out the latest information here.

Marcus DaSilva Goncalves, M.D., Ph.D.

Endocrinology, Diabetes and Metabolism

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

I am an endocrinologist and laboratory scientist (https://www.goncalveslab.com/) interested in how the body stores and metabolizes nutrients. My lab uses animal models and human clinical trials to understand the effects of diet (e.g. ketogenic, fructose) and cancer on the metabolic pathways that control fat and muscle mass. My clinical practice is focused on metabolic diseases that are associated with high blood sugar (prediabetes, diabetes, fatty liver disease, high cholesterol) or the loss of skeletal muscle mass (low testosterone, cancer cachexia, etc).

Biographical Info

Born and raised in central New Jersey

Undergraduate/Masters degrees (BS/MSE) in Biomedical Engineering from the Johns Hopkins University

Medical degree and scientific doctorate (MD/PhD) in Cell and Molecular Biology from the University of Pennsylvania

Medical Internship, Residency, and Endocrinology fellowship at the Weill Cornell Medical Center, New York Presbyterian Hospital, Memorial Sloan Kettering Cancer Center, and Hospital for Special Surgery joint program.

Honors and Awards

2019      ASCI Young Physician-Scientist Award

2019      Feature Article in New York Presbyterian: Advances in Endocrinology.

2018      Awarded a scientific grant from the NIH

2018      Endocrine Society Outstanding Abstract Award (ENDO 2018)

2017      Awarded a scientific grant from the Lung Cancer Research Foundation

2016      Feature Article in New York Presbyterian: Advances in Endocrinology.

2015      Science National Honor Society, honorary member awarded by Jackson Memorial High School

2012      Peterman-Arnold Medical Student Award for Endocrinology Research        

2006      Fontaine Scholar

2006      Medical Scientist Training Program, NIH

2005      Seward Scholar

2001      Hodson Trust Scholar

2001      American Chemical Society Scholar

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Endocrinology, Diabetes, and Metabolism)
Clinical Expertise
Cachexia
Muscle Wasting
Hypogonadism
Pre-Diabetes
Insulin Resistance
Non-Alcoholic Fatty Liver Disease
Diabetes Mellitus, Type 2
High Cholesterol
High Triglycerides
Languages
English
Education 
  • M.D.
    University of Pennsylvania School of Medicine
    2012
  • Ph.D.
    University of Pennsylvania
    2010
  • M.S.E.
    The Johns Hopkins University
    2006
  • B.S.
    The Johns Hopkins University
    2004
Appointments 
  • Assistant Attending Physician
    NewYork-Presbyterian Hospital
  • Assistant Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Ralph L. Nachman Research Scholar
    Weill Cornell Medical College, Cornell University
  • Associate Attending Physician
    NewYork-Presbyterian Hospital
  • Associate Professor of Medicine
    Weill Cornell Medical College, Cornell University
  • Associate Professor of Biochemistry
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Consultant: 
Novartis Pharma AG
Scorpion Therapeutics, Inc.
Professional Services: 
FAETH Therapeutics
Ownership: 
FAETH Therapeutics
Proprietary Interest: 
FAETH Therapeutics